Wei-Cheng Huang, Jane-Ming Lin, Chun-Chi Chiang, Yi-Yu Tsai. Show Affiliations »
Abstract
Entities: Chemical
Mesh： See more » Angiogenesis Inhibitors/administration & dosageAngiogenesis Inhibitors/therapeutic useAntibodies, Monoclonal/administration & dosageAntibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, HumanizedBevacizumabChoroidal Neovascularization/drug therapyChoroidal Neovascularization/etiologyFluorescein AngiographyHumansInjectionsIntraocular PressureMacular Degeneration/complicationsMacular Degeneration/drug therapyParacentesisPhotochemotherapyPhotosensitizing Agents/therapeutic usePorphyrins/therapeutic useTomography, Optical CoherenceVascular Endothelial Growth Factor A/antagonists & inhibitorsVerteporfinVisual AcuityVitreous Body
Substances： See more » Angiogenesis InhibitorsAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedPhotosensitizing AgentsPorphyrinsVascular Endothelial Growth Factor AVerteporfinBevacizumab
Year: 2008 PMID： 18779502 DOI： 10.1001/archopht.126.9.1314
Source DB: PubMed Journal: Arch Ophthalmol ISSN： 0003-9950